Wall Capital Group’s Merck MRK Stock Holding History

Wall Capital Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,015	Closed	-$204K	–	27
2018 Q3	$204K	Buy	+3,015	New	+$192K	0.1%	25

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wall Capital Group's MRK Position: Q4 2018 in Review

Wall Capital Group sold out of Merck (MRK) in Q4 2018, closing a stake of 3,015 shares — an estimated $204K sold.

Wall Capital Group first reported a position in MRK in Q3 2018 and held it in 1 quarter. The position peaked at $204K in Q3 2018. 2,251 funds tracked by Wall St. Rank hold MRK as of Q4 2018.

Wall Capital Group reported no remaining Merck position as of Q4 2018 after selling out during the quarter.
Wall Capital Group sold 3,015 Merck shares in Q4 2018, an estimated $204K.
Wall Capital Group first reported a position in Merck in Q3 2018 and held it in 1 quarter.
Wall Capital Group's Merck position peaked at $204K in Q3 2018.
2,251 funds tracked by Wall St. Rank held Merck as of Q4 2018.

Based on Wall Capital Group's 13F filing for Q4 2018, filed 15 Jan 2019.